ANTI-HBC IgG LEVEL IN PREDICTION OF HBsAg SEROCLEARANCE IN CHRONIC HEPATITIS B PATIENTS WITH NUCLEOS(T)IDE ANALOGUE INDUCED HBEAG SEROCLEARANCE

被引：0
|
作者：
Kim, Saein [1 ]
Lee, Hyun Woong [1 ]
Lee, Jung Il [1 ]
Lee, Kwan Sik [1 ]
机构：
[1] Yonsei Univ, Coll Med, Gangnam Severance Hosp, Dept Internal Med, Seoul, South Korea
来源：
HEPATOLOGY | 2019年 / 70卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
666
引用
收藏
页码：417A / 417A
页数：1
相关论文
共 50 条
  • [31] THE APPLICATION OF RISK SCORES IN PREDICTION OF HCC IN CHRONIC HEPATITIS B PATIENTS WITH HBsAg SEROCLEARANCE
    Jeng, Rachel Wen-Juei
    Pan, Mei-Hung
    Chen, Chien-Jen
    Yang, Hwai-I
    HEPATOLOGY, 2023, 78 : S495 - S496
  • [32] Sustained off-treatment viral control is associated with high hepatitis B surface antigen seroclearance rates in Caucasian patients with nucleos(t)ide analogue-induced HBeAg seroconversion
    Van Hees, Stijn
    Chi, Heng
    Hansen, Bettina
    Bourgeois, Stefan
    Van Vlierberghe, Hans
    Serste, Thomas
    Francque, Sven
    Wong, David
    Sprengers, Dirk
    Moreno, Christophe
    Nevens, Frederik
    Janssen, Harry L. A.
    Vanwolleghem, Thomas
    JOURNAL OF VIRAL HEPATITIS, 2019, 26 (06) : 766 - 769
  • [33] HBsAg spontaneous seroclearance in a cohort of HBeAg-seronegative patients with chronic hepatitis B virus infection
    Han, Zhen-Ge
    Qie, Zhong-Hong
    Qiao, Wei-Zhen
    JOURNAL OF MEDICAL VIROLOGY, 2016, 88 (01) : 79 - 85
  • [34] Long-term outcomes and significance of HBeAg Seroclearance in Chronic Hepatitis B: Novel Predictive Scores for HCC and HBsAg seroclearance
    Fung, Y. Y. J.
    Cheung, K. -S.
    Wong, D.
    Mak, L. -Y.
    To, W. P.
    Seto, W. -K.
    Lai, C. L.
    Yuen, M. -F.
    JOURNAL OF HEPATOLOGY, 2018, 68 : S486 - S487
  • [35] Incidence and predictors of hepatitis B surface antigen seroclearance after cessation of nucleos(t)ide analogue therapy in hepatitis B e antigen-negative chronic hepatitis B
    Jeng, Wen-Juei
    Chen, Yi-Cheng
    Chien, Rong-Nan
    Sheen, I-Shyan
    Liaw, Yun-Fan
    HEPATOLOGY, 2018, 68 (02) : 425 - 434
  • [36] HBSAG SEROCLEARANCE AFTER TREATMENT-INDUCED HBEAG SERO CLEARANCE IN CHRONIC HEPATITIS B PATIENTS IN BEIJING, CHINA
    Wang, L.
    Cheng, K.
    Duan, Z.
    Chen, Y.
    Zhao, X.
    Xu, M.
    Wang, Y.
    VALUE IN HEALTH, 2016, 19 (07) : A509 - A509
  • [37] Effect of nucleos(t)ide analogue on serum HBsAg level in chronic hepatitis B patients: A 3-years study
    Zheng, Zhidan
    Liao, Wei
    Liu, Lili
    Cai, Shaohang
    Zhu, Haipeng
    Yin, Sichun
    BIOMEDICINE & PHARMACOTHERAPY, 2020, 122
  • [38] Stopping Nucleos(t)ide Analogue Therapy in HBeAg-Negative Chronic Hepatitis B
    Liaw, Yun-Fan
    GASTROENTEROLOGY, 2020, 159 (03) : 1186 - 1186
  • [39] HbsAg decline and HbsAg seroclearance in chronic hepatitis B patients on nucleos(t)ide analogues or pegylated interferon therapy a systematic review and model-based meta-analysis
    Slaets, Leen
    Verbinnen, Thierry
    Beumont, Maria
    De Ridder, Filip
    Lenz, Oliver
    Meyvisch, Paul
    HEPATOLOGY, 2017, 66 : 14A - 14A
  • [40] The safety of stopping nucleos(t)ide analogue treatment in patients with HBeAg-negative chronic hepatitis B
    Wong, Grace L. -H.
    Chan, Henry L. -Y.
    Yuen, Becky W. -Y.
    Tse, Yee-Kit
    Luk, Hester W. -S.
    Yip, Terry C. -F.
    Hui, Vicki W. -K.
    Liang, Lilian Y.
    Lee, Hye-Won
    Lui, Grace C. -Y.
    Wong, Vincent W. -S.
    LIVER INTERNATIONAL, 2020, 40 (03) : 549 - 557
12345